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Abstract
Brain monitored level of propofol hypnosis provides a numerically reproducible para-
digm to block negative ketamine side effects. 50 mg IV ketamine 3 minutes prior to local 
anesthetic injection blocks virtually all midbrain NMDA receptors and is the basis for 
nonopioid preemptive analgesia. Opioid avoidance essentially eliminates postoperative 
nausea and vomiting (PONV) as well as the need for antiemetic agents. Over the past 
20 years, no elective cosmetic surgical cases required hospital admission for either post-
operative pain control or PONV.
Keywords: brain monitoring, BIS/EMG, propofol, ketamine, nonopioid preemptive 
analgesia (NOPA), PONV
1. Introduction
Elective cosmetic surgery excludes medically indicated procedures like postmastectomy breast 
reconstruction, burn and tendon repair that are the more properly included in the area of 
plastic surgery. As such, general anesthesia (GA) risks that may be acceptable for medically 
indicated, plastic surgery patients may not be acceptable for elective cosmetic surgery patients. 
Cosmetic surgery is “want to” surgery. Plastic surgery is “have to” surgery.
While all cosmetic surgery can be performed under local anesthesia only, most surgical candi-
dates desire to not hear, feel or remember their procedures. Most surgeons prefer to concen-
trate on their surgery and not to have to speak with their patients during surgery. As such GA 
is commonly requested by many surgeons. Brain monitored propofol ketamine (“Goldilocks”) 
anesthesia (not too much, not too little, but just right) bridges the patient care gap between 
surgery under local only and the more commonly performed GA. “Goldilocks” anesthesia 
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simulates GA conditions (nonverbal, predominantly immobile patients) while trespassing the 
least on patient physiology, satisfying both patient and surgeon desires. “Goldilocks” anes-
thesia is numerically reproducible. “Goldilocks” anesthesia embodies Friedberg’s triad; i.e. 
Measure the brain, Preempt the pain, Emetic drugs abstain (Figure 1).
2. Direct cerebral cortical (brain) monitoring
When you can MEASURE what you are speaking about, and express it in NUMBERS, you know 
something about it; but when you cannot measure it, when you cannot express it in numbers, your 
knowledge is of a meager and unsatisfactory kind; it may be the beginning of knowledge, but you have 
scarcely, in your thoughts, advanced to the stage of SCIENCE.
William Thompson, knighted Lord Kelvin Popular lectures and addresses 1891–1894.
What was true for temperature measurement more than a century ago is also true for the 
direct measurement of patient’s cortical response to anesthetics. Without such measurement, 
there can be no science. Without science, there can be no reproducibility across the broad, 
and often unpredictable yet well-recognized, spectrum of individual patient response to 
medications.
Brain weight does not vary with body weight (i.e. the brain weight of a 100-kg male is NOT 
twice that of a 50-kg female). Traditional anesthetic dosing based on body weight does not 
account for individual sensitivities to medications and is, therefore, frequently in error.
Further adding to the possibility of dosing error is the twentieth century practice of rely-
ing on heart rate (HR) and blood pressure (BP) changes to ascertain cortical drug response. 
HR and BP changes primarily reflect brain stem response but are unreliable to accurately 
determine cortical response. Prior to the ability to measure cortical response, the knowledge 
gap between brain stem and cortical response led to routine overmedication (to avoid under 
medication with awareness and recall).
Figure 1. Friedberg’s triad.
Anesthesia Topics for Plastic and Reconstructive Surgery36
Pain and consciousness are processed at higher cortical levels (Figure 2). Fifty percent of 
patients experiencing awareness with recall under anesthesia had no HR or BP changes with 
which to alert their anesthesiologist [1]. Preventing anesthesia awareness is the least impor-
tant value of direct brain monitoring. No deaths have yet been reported from anesthesia 
awareness. However, one American overmedication death occurs daily! [2]. Preventing over 
medication is the major value of direct brain monitoring (Figure 3).
Complex mathematical modeling, i.e. pharmacodynamics (PD) and pharmacokinetics (PK), 
is based on body weight that may not accurately reflect individual cortical sensitivities. While 
currently unavailable in the US, target controlled infusion (TCI) only infers cortical response 
based on blood drug concentrations, again with possible error.
With the Federal Drug Administration (FDA) 1996 approval of the bispectral index™ (BIS) 
brain monitor, the promise of direct measurement of cortical hypnotic response to anesthetic 
drugs was made available to the anesthesia community. Competing cortical monitors have 
been introduced since 1996, but the BIS monitor remains the most well-validated brain moni-
tor on the market to date.
Anesthesia may be defined as the sum of hypnosis plus analgesia (Figure 4). Implicit in “hyp-
nosis” is amnesia for surgery and within “analgesia” is sufficient muscle relaxation to imbri-
cate the rectus abdominis sheath for classical abdominoplasty. Measured hypnosis enables 
differentiation of cortical- versus spinal cord–originated patient movement. As opposed to 
cortically originating patient movement, spinal cord–originated patient movement is devoid 
of awareness with recall concerns. Knowledge of the origin of patient movement facilitates 
origin-appropriate treatment of patient movement, thus assuring adequate local anesthesia 
during sedation (Table 1).
As an index, the BIS scale is from 0 to 100. The lower the number, the deeper the level of 
hypnosis (Table 2). Although validated in over 3500 published papers, the promise of direct 
Figure 2. Cortex and brain stem.
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brain monitoring has remained unrealized for several reasons. First, the BIS only measures 
response to hypnotic, not analgesic, drugs primarily acting of the cerebral cortex like propo-
fol and inhalation agents like isoflurane, sevoflurane and desflurane. Drugs that act at lower 
brain centers are benzodiazepines (i.e. diazepam and midazolam), opioids (i.e. morphine, 
meperidine, hydromorphone, fentanyl, sufentanil, alfentanil, remifentanil), and N
2
O. One 
cannot depend on reliable BIS cortical measurement from subcortically acting agents.
Second, the original factory default setting included only the BIS value and horizontally dis-
played BIS trend. BIS values are calculated by an algorithm that delays data by 15–30 s from 
real time. This delay puts the anesthesiologist in the unfavorable position of catching up to 
dynamically changing patient hypnotic requirements as opposed to having real-time infor-
mation with which to formulate a response ahead of patient movement. BIS without EMG is 
not useful and is akin to trying to drive a car with only the rearview mirror information.
The electromyogram (EMG) is the electrical activity of the frontalis muscle between the eye-
brows. This EMG is as real time and as instantaneous a signal as that of the EKG of the cardiac 
muscle. Unfortunately, the EMG was originally perceived as a “contaminant” of the BIS signal 
and not understood as a useful piece of information. Prompt attention to EMG spikes during 
sedation by increasing sedation to return the activity to baseline precludes “contamination” 
of the BIS value. Trending EMG spike activity enables the anesthesiologist to proactively 
respond to rapidly changing patient needs, providing a stable level of hypnosis throughout 
a case. BIS with EMG trending is very useful and is akin to driving a car looking through the 
forward-facing windshield.
Figure 3. Hypnosis + analgesia = anesthesia.
Anesthesia Topics for Plastic and Reconstructive Surgery38
Anesthesiologists process information most consistently on the horizontal sweep as displayed 
in the EKG and SpO
2
 trends. EMG is displayed on the original factory default, but only as a 
vertical column. Contained in the software of every free-standing BIS unit is the option to 
select EMG and save it to trend below the BIS trend on a horizontal sweep display. As of 2017, 
the factory default setting now displays both BIS and EMG trends. However, the lower EMG 
trend as pictured by the recent company literature is without important EMG spikes.
There are two vertical numerical scales on either side of the BIS monitor display (Figure 5). 
The left side scale (yellow) for the BIS is from 0 to 100. The right side scale (red) is from 30 to 
Figure 4. The value proposition of direct cortical monitoring.
BIS values Hypnotic sedation/anesthesia levels
98–100 Awake
78–82 Minimal sedation
70–80 Moderate sedation
60–70 Deep sedation
45–60 + systemic analgesia General anesthesia
<45 OVERMEDICATED
Table 1. BIS values and hypnotic sedation/anesthesia levels.
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100 for the EMG. Spikes in EMG signify incipient patient arousal demanding an increase in 
propofol (or inhalational agent) sufficient to return the EMG to baseline (i.e. 0 on the top BIS 
scale and 30 on the bottom EMG scale). (Figure 6).
In the pre-BIS era, anesthesiologists considered the absence of HR and BP changes with skin 
incision to define adequate depth of anesthesia. Nondissociative attempts at preemptive anes-
thesia have met with variable successes. Postoperative pain management continues to be an 
issue. HR and BP primarily reflect brain stem changes, while pain and consciousness are pro-
cessed at higher cortical levels. Twenty-first century standard of care anesthesia monitoring 
demands cortical monitoring as a standard of care. It is an untenable assertion that 16 million 
of the 40 million (40%) American patients every year emerge from anesthesia with “brain fog” 
caused by a previously undiagnosed, underlying condition. Without numerically measuring 
the depth of sedation/anesthesia, discovering the role of routine overmedication in postopera-
tive “brain fog” will be problematic [3].
Figure 5. BIS VISTA monitor.
Propofol titrated to 60 < BIS < 75 with baseline EMG indicated an asleep, amnestic patient.
A blanched surgical field does not equal adequate local analgesia.
Surgery below the clavicles with patient movement without EMG activity indicates more local analgesia in the 
immediate area of stimulation.
Table 2. The surgeon’s golden rules for success with brain monitored propofol ketamine.
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Once sedated, the brain cannot differentiate the signal from a well-intentioned surgeon’s scal-
pel (or trocar) and the malevolent intentions of a mugger’s knife. Success with preemptive 
analgesia makes it imperative to prevent the brain from receiving the noxious input from 
the violation of the integument’s barrier to the outside world of danger. Although other pain 
receptors exist within the body, the most significant information to prevent the wind-up phe-
nomenon and postoperative pain is that of skin incision.
The N-methyl, D-aspartate (NMDA) receptors in the midbrain are the final gatekeepers of 
noxious input to the cortex. Ketamine is a major NMDA antagonist (propofol has substan-
tially less NMDA antagonism than ketamine). When the initial local anesthetic injection is 
performed (common to virtually all elective cosmetic surgeries), the absence of an EMG 
spike with multiple local anesthetic injections defines midbrain NMDA receptor saturation 
and creates nonopioid, preemptive analgesia.
Absent the ability to differentiate cortical- from spinal cord–originating movement during 
sedation forced anesthesiologists to treat every patient movement “as if” the patient might 
be awake and recall his or her surgery. All patient movement does not have the same signifi-
cance. Like GA, “Goldilocks” anesthesia requires patients to be retrained on the operating 
table. Patient movement per se can be generated without cortical input, i.e. from spinal cord 
reflexes. A headless chicken still generates movement.
No spinal cord pathways exist to activate the facial frontalis muscle. During the case, patient 
movement without an EMG spike is an indication for additional local anesthesia in the imme-
diate area of surgical stimulation. Only after two attempts of reinjection after the initial injec-
tion (three total injections) fails to eliminate patient movement should additional ketamine 
be given. Conversely, if patient movement is accompanied by an EMG spike, both additional 
local anesthesia and additional propofol should be administered. Additional local anes-
thetics should cause the patient movement to cease in the overwhelming majority of cases. 
Additional propofol must be administered in sufficient amounts to return the EMG to base-
line to maintain the patient unconscious and amnestic.
It is not the absolute value (or spike) of any individual BIS reading that may determine recall. 
Rather, it is the area under the trend curve. Three to five minutes of a BIS >80 will more likely 
produce recall than less area under the curve. Restraint from the surgeon or operating room 
staff making loud, negative comments with patient movement deprives the unconscious 
patient subliminal input with which to process memories. One cannot control the emotional 
maturity of the personnel in the operating room. Many times, demonstrating to both the sur-
geon and his staff of an objective numerical measure of the patient’s level of consciousness 
(i.e. BIS < 75 with baseline EMG) can calm otherwise overanxious personalities and preserve 
a peaceful operating room.
The use of EMG spike activity enables the differentiation between cortically generated patient 
movement and that originating from the spinal cord. Conducting a cosmetic surgery case in 
this fashion assures the patient receives critical adequate local anesthesia for the case and sets 
the stage for minimal postoperative pain management.
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Over the past two decades of experience in >4000 patients, the infrequent postoperative dis-
comfort was readily managed with intravenous (IV) ketorolac 30–60 mg and/or oral acet-
aminophen 1000 mg. Rapid propofol emergence allowed patients who did request additional 
analgesia to safely swallow oral acetaminophen without aspiration risk. Higher acetamin-
ophen blood levels are unquestionably achieved with the IV versus the oral preparation. 
However, since adequate pain relief was observed with the oral form, cost considerations 
precluded the use of IV acetaminophen. Very few patients required IV fentanyl (25–100 mcg) 
for pain management. The author’s experience was entirely in the office-based setting. There 
were no postoperative hospitalizations for postoperative pain management during the period 
1992–2017 in >6000 patients.
Figure 6. Why BIS is not commonly utilized.
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Prior to BIS/EMG monitoring, treating all movement left many patients overmedicated and 
unable to quickly emerge from anesthesia to go home or to a recovery center. Patient move-
ment during sedation was generally regarded by the surgeon that the patient was “too light” and 
needed more sedation. Anesthesiologists often responded to the surgeon’s demand with “needs 
more local.” A circular argument ensued, physicians’ feelings got bruised, but more importantly, 
the patient was ill-served, overmedicated, and often, with postoperative pain management issues.
The net effect of pre-BIS/EMG sedation attempts resulted in many surgeons encouraging (or 
even demanding) the abandonment of sedation in preference to GA with neuromuscular 
blocking agents. GA exposes the elective cosmetic surgery patient to the unnecessary risks 
of difficult intubation, failed intubation, misplaced endotracheal tube (ET), esophageal or 
endobronchial intubation, kinked or occluded ET, teeth damage, anesthesia machine mishaps 
(i.e. empty vaporizer, vaporizer filling error, reversed oxygen and nitrous oxide gases) and, 
very rarely, malignant hyperthermia (MH). No endotracheal intubations were required in the 
author’s 25-year experience.
The advent of the use of the laryngeal mask airway (LMA) has greatly reduced or eliminated 
many ET issues. This author routinely places an armored (or flexible) LMA for rhinoplasty 
cases both to cover the glottic chink and using the inflatable cuff to prevent blood from enter-
ing the esophagus. For nonrhinoplasty cases, airway management is dependent upon patient 
response (Table 3).
The very small MH risk necessitates any GA facility stocking dantrolene, an expensive agent 
with a 3-year shelf life. Delays in treating MH are prompt recognition due to its rare occur-
rence and partly due to the difficulty of dissolving the treatment into solution to administer. 
A newer formulation of dantrolene (i.e. Ryanodex®) is easier to dissolve into solution for 
administration but may not be widely found.
Neither propofol nor ketamine is a triggering agent for MH. The early diagnosis of MH is 
most often made by unexplained tachycardia. Tachycardia is frequently observed following 
the injection of epinephrine containing local anesthesia at the beginning of the case. When 
the injection is temporally associated with the dissociative ketamine dose, some are more 
apt to believe the ketamine, not the epinephrine, was the source of the tachycardia. Often, 
in the performance of “Goldilocks” anesthesia, incremental propofol induction followed the 
ketamine, but the surgeon did not inject the local analgesia by as along as 10 minutes after the 
Chin extended, head rotated to the side (initially to the right but sometimes better airway results turning to the left).
IV bag (not heated) under the shoulders (not the neck), increasing the force of extension on the genioglossus muscle.
#28 Fr latex (or latex free) lubricated nasal airway, often better tolerated than oral airways.
#4 LMA.
N.B. 50–60% of brain monitored PK cases/25 years have been performed without airway instrumentation. No 
endotracheal intubations required in 25 years, >6000 patients.
Table 3. Airway management flow chart (assumes incremental propofol induction).
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ketamine administration. No tachycardia or hypertension was observed when ketamine was 
administered well prior to the lidocaine with epinephrine solution injection. Nontriggering 
“Goldilocks’” anesthesia also means surgical facilities need not stock dantrolene.
3. Propofol
Propofol is a 1,4-diisopropyl quinol with sedative-hypnotic properties. Because of its slight 
solubility in water, the drug is formulated as an emulsion for clinical use. It is highly lipophilic 
and distributes extensively in the body. The drug was introduced to the North American 
market in 1989 and has largely displaced both thiopental and methohexital for induction of 
general anesthesia and maintenance of sedation.
Propofol’s rapid metabolism accounts for its short activity. It is also a potent antiemetic, espe-
cially in the absence of concomitant opioid administration. Only after much experience with 
the drug for sedation was the patients’ clear head and happy affect after emergence was this 
quality appreciated by the author. Unfortunately, these qualities have also made propofol a 
drug of abuse within small numbers of the profession (“white rabbit”) as well as by celebrities 
like Michael Jackson.
Propofol also results in inhibition of the N-methyl, D-aspartate (NMDA) subtype of gluta-
mate receptor [4]. Lack of recall was observed in 95% of patients at BIS of 77 [5]. Propofol at 
25–50 mcg/kg/min was sufficient to produce sedation to 60 < BIS < 75 with baseline EMG for 
many patients. However, as little as 2.5 mcg/kg/min and as much as 200 mcg/kg/min have 
been required to achieve the same numerically defined level of sedation at 60 < BIS < 75 with 
baseline EMG. This 20-year experience represents nearly a hundred-fold variation in propofol 
requirements. Incrementally inducing patients starting with 50 mcg/kg propofol miniboluses 
(Watch YouTube Propofol induction with BIS monitor without instrumenting airway) allows the 
anesthesiologist to identify outliers early in the case and enables all patients to receive “not 
too much, too little, but just the right amount” and not to hear, feel or remember their surgery. 
The expression “not too much, too little, but just the right amount” is the basis for using the 
shorthand expression “Goldilocks” anesthesia. Those unfamiliar with the Goldilocks story 
should watch YouTube Goldilocks and the Three Bears—Fairy Tales.
Textbook doses for propofol sedation do not discuss the value of incremental induction not only 
to identify outliers but also to dramatically minimize airway management and eliminate pre-
cipitous blood pressure drops. Incremental propofol induction more often maintains the airway 
patency by preserving muscle tone of the temporalis, masseter, genioglossus and orbicularis oris.
Propofol was introduced to North America in 1989 and quickly replaced both thiopental and 
methohexital as the preferred induction agent. As a proprietary agent, a 20 cc propofol bottle 
retailed around $12–15 USD, making a continuous infusion for surgery apparently prohibi-
tive for multihour surgeries in a cost-conscious office-based cosmetic surgery suite.
After five years of performing propofol ketamine (PK) intravenous sedation using an average 
three 20 cc bottles of propofol per hour, the author’s surgeons kept clamoring for a less expensive 
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way to administer it, especially for 4–6 hours rhytidectomies with or without browlifts, pla-
tysmal plications or blepharoplasties. Five years of data on 1264 patients demonstrated no 
reduction in propofol requirements with either 2 or 4 mg preoperative midazolam as admin-
istered [6].
This same paper [6] also published the lowest postoperative nausea and vomiting (PONV) 
rate (0.6%) in the literature without antiemetic use in an Apfel-defined high-risk patient popu-
lation, i.e. nonsmoking females with positive PONV and/or motion sickness histories, having 
emetogenic (cosmetic) surgery. Scrupulous opioid avoidance both during and after surgery 
has allowed this astounding PONV rate to go unchallenged to date.
Aspect Medical Systems (Aspect Medical Systems, a venture capital company, was purchased 
by Medtronic that has subsequently been acquired by Covidien) exhibited their bispectral 
index monitor™ (BIS) for measuring cortical effect at the 1997 International Anesthesia 
Research Society (IARS) annual meeting in San Francisco. The author was exhibiting his 
Society for Office Anesthesiologists (SOFA) at the same meeting and was initially exposed 
to the BIS monitor there. The BIS monitor appeared to offer more promise reducing propofol 
requirements than previous efforts with midazolam premedication [6]. Later work validated 
that promise [7, 8]. Entropy™ is another depth of anesthesia monitor but has not been vali-
dated in nearly as many clinical papers as BIS [9].
4. Ketamine
In the 1950s, postoperative pain was treated with morphine or meperidine, often undertreated 
for two reasons: (a) fear of producing opioid addiction and (b) problems of overtreatment, 
respiratory insufficiency or apnea and death. Naloxone was not introduced until 1971 and 
pulse oximetry became commercially available in 1983.
The researchers of the day postulated that, if another class of drugs could be developed that 
would ameliorate pain without respiratory depression, patients could be better treated for 
postoperative pain with neither under- nor overtreatment.
The first class of drugs explored was the phencyclidines. The parent compound, phencyclidine 
phosphate, was marketed as Serenyl® by Parke-Davis in 1958 but was quickly withdrawn 
from the market because of the high percentage of undesirable side effects, i.e. hallucina-
tions, mania, delirium and disorientation. Later, phencyclidine phosphate, as a drug of abuse, 
became better known by the initials, PCP or “angel dust.”
The researchers did not give up quickly on the phencyclidine class. They began experiment-
ing with a modified PCP molecule, ketamine, which received FDA approval in humans in 
1971. The drug, like its predecessor, was introduced as the “silver bullet,” a complete, total 
intravenous agent, meaning no other agents were needed. Because it supported both respira-
tion and blood pressure, ketamine quickly gained a reputation as a safe drug but one not good 
for adult patients. It did become popular in children’s burn units, especially for the extremely 
painful dressing changes.
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During the author’s anesthesia residency at Stanford 1975–1977, he was introduced to 
administering ketamine in small doses (10–20 mg IV) prior to positioning elderly patients 
about to receive spinal anesthesia for surgery on femoral head or shaft fractures. Elderly 
patients were not particularly susceptible to ketamine-associated hallucinations or dyspho-
rias. Veterinarians also adopted ketamine, quickly realizing that it was nearly impossible 
to kill an animal, even if the per body weight dose was more than twice the recommended 
amount. Also, the animals did not complain about hallucinations. While ketamine was a safe 
drug, two generations of human anesthesiologists have avoided its use in adult day surgery. 
Sometime during the mid-1970s, a Las Vegas plastic surgeon, Charles Vinnik, wearied listen-
ing to his patients cry out when he injected local anesthesia under his self-directed diazepam 
and meperidine IV sedation. Even though the patients had amnesia for the experience, the 
patients’ cries were distressing to the OR staff. Vinnik asked his anesthesiologist if there was 
anything else he could use that would eliminate the distressing reactivity of the patients. 
Ketamine was suggested. Ketamine was first synthesized by Stevens in 1962 and first used in 
humans by Domino and Corssen in 1965. The drug was used in clinical practice barely 5 years 
when its use was suggested to Vinnik.
Through trial and error, Vinnik came upon his initial ketamine dose of 75 mg independent 
of body weight to prevent the patients from either moving or crying out after they were ren-
dered sleepy from incremental doses of intravenous diazepam. Vinnik began with his test 
dose of 10 mg diazepam administered through an external jugular (to avoid venous thrombo-
sis), followed by 5–10 mg increments to a total of 25–50 mg. Vinnik had his patients engage a 
24-hour nurse to observe them after discharge to home. His cost-effective concept meant the 
cost of the recovery nurse did not come from him.
Although Vinnik published his diazepam-ketamine technique (i.e. hypnosis first, then dis-
sociation) without the reported hallucinations or dysphorias, the 1981 paper appeared in 
the plastic surgery literature [10]. Vinnik’s approach lay largely unnoticed in the anesthesia 
community until the author heard him speak in Newport Beach, CA, in December 1991, later 
visiting his office operating room in March 1992.
The author considered Vinnik’s use of ketamine useful but doubted diazepam would be an 
optimal drug for day cases expected to return to home. Propofol was then considered as an 
alternative to diazepam for hallucination-blocking purpose. Searching the anesthesia litera-
ture to support this use of propofol turned up no useful information. March 26, 1992 was the 
beginning of this author’s clinical trial of propofol followed by ketamine [11]. In the 1990s, 
ketamine became a drug of abuse, a “rave” drug and later lumped together with flunitraz-
epam and gamma hydroxybutyrate (GHB) as “date rape” drugs. Ketamine is also a drug of 
abuse. Heavy users can develop long-term bladder or urinary tract damage and incontinence.
Anesthesia trainees continue to be taught ketamine causes tachycardia, hypertension and 
hallucinations despite the knowledge that benzodiazepines [12] or propofol hypnosis blocks 
ketamine hallucinations [13]. In the pre-BIS era, loss of lid reflex and loss of verbal response 
defined adequate hallucination-blocking depth of propofol hypnosis. With real-time BIS/
EMG monitoring, the level of hallucination-blocking propofol hypnosis is more numerically 
defined as 60 < BIS < 75 with baseline EMG. Some believe the use of ketamine defeats the 
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ability of the BIS monitor to accurately measure propofol. This study compared ketamine 
doses of 0.2–0.5 mcg/kg and concluded 0.5 mcg/kg would defeat the BIS [14]. An earlier 
publication using 50 mg ketamine, independent of body weight, confirmed BIS’ utility [15].
More controversial is the author’s use of 50 mg ketamine independent of body weight. Brain 
weight does not vary with body weight (i.e. the brain weight of a 100-kg male is not twice that 
of a 50-kg female). The midbrain is a very small portion of the total brain weight. The NMDA 
receptors are a small part of the very small midbrain. After observing the same immobility (or 
dissociative effect) in 100-kg males as in 50-kg females, body weight was not deemed a con-
sideration for effective ketamine dose. With the addition of BIS/EMG monitoring, absence of 
EMG spike is considered numerically reproducible evidence of NMDA saturation and nono-
pioid, preemptive analgesia.
In many third world countries, ketamine infusions are still to be found as the drug was origi-
nally marketed. However, as propofol has become generic and very inexpensive, more anes-
thesia providers from third world countries have accessed the author’s web site to obtain 
information with which to execute the PK paradigm.
Ketamine, ironically, is the perfect adjuvant drug (or the ‘olive’ in the propofol ‘martini’) not 
the complete and total intravenous agent its makers originally intended it to be, at least in the 
western world.
Brain monitored PK IV sedation is less expensive, safer and simpler and gives better out-
comes (i.e. virtually no PONV [16] and minimal postoperative pain). With ability to stratify 
anesthesia outcomes by depth of anesthesia and the negative effects of routine anesthesia 
overmedication (i.e. BIS <45), studies have demonstrated more apparent negative effects from 
this practice [17–20]. Postoperative cognitive dysfunction (POCD) is the name for the pseudo-
Alzheimer’s type of confusion seen more often in elderly, rhytidectomy patients. Sometimes 
this lasts hours, days, weeks or months. Sometimes the effects are not transitory. Rapid emer-
gence does not preclude intraoperative overmedication. Patients are left with the long-term 
consequences of their anesthesiologist’s short-term care.
The brain monitored PK IV sedation technique also gives providers the ability to refrain from 
the nefarious practice of routinely overmedicating patients for fear of undermedicating them.
5. Putting brain monitored propofol ketamine (“Goldilocks”) anesthesia 
into practice
Teaching the technique is simple. Teaching cooperation is not.
Daniel HS Lin, DO, Cosmetic surgeon
Along with the patient, many egos enter the operating room, not the least of which is that 
of the surgeon’s. The surgeon’s cooperation with local anesthesia is essential for success. 
The surgeon must also understand the need for adequate local anesthesia. Surgeon perfec-
tion injecting local analgesia is not a requirement, only persistence. Surgeons typically 
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equate a blanched surgical field with adequate analgesia. Only with brain monitoring can 
the anesthesiologist hope to convince the surgeon that a blanched field only equals adequate 
vasoconstriction.
Prompt essentially PONV free and minimal pain recovery are the hallmarks of “Goldilocks” 
anesthesia. Once the surgeon observes how much better his patients do postoperatively, the 
need for his/her cooperation should become apparent. The office-based setting has a higher 
incentive for surgeon cooperation. Recovery space is limited and personnel are often multi-
tasked compared with free-standing or hospital-attached day surgery center facilities. As 
superior and numerically reproducible as the “Goldilocks” anesthesia outcomes are, there 
are still surgeons reluctant to cooperate. Just as disappointing is the numbers of anesthe-
siologists who remain shackled to the outdated teachings that ketamine causes hallucina-
tions, hypertension and tachycardia or are unwilling to reconsider using real-time BIS/EMG 
to titrate propofol.
The clinical pathway for brain monitored propofol ketamine (“Goldilocks”) anesthesia is a 
simple straightforward three-drug technique: glycopyrrolate, propofol and ketamine. Induce 
hypnosis first, next dissociate, then inject local analgesia (Table 4). (Atropine may be sub-
stituted when glycopyrrolate is unavailable. Tachycardia will more commonly result than 
administering glycopyrrolate). Unexplained tachycardia, not temperature elevation, is the 
cardinal recognition sign for MH. Once the brain is protected with propofol incrementally 
titrated to loss of lid reflex/loss of verbal response or 60<BIS<75 with baseline EMG, the 50mg 
ketaamine by itself does not cause tachycardia or hypertension!
Prior to placing the BIS sensor on the forehead, the patient is advised the number from their 
forehead allows them to “control” their anesthetic dose. This control means that neither too 
much nor too little can be given. Then the patient is encouraged to touch the sensor pad to 
assure them their skin cannot be scarred even though the sensor application will be a little 
uncomfortable. A small discomfort for a great relief about anesthetic dosing is greatly appre-
ciated by patients. Patients are additionally advised that 5% or one in 20 may have pleasant, 
colorful dreams.
The preoperative consultation includes disclosure of the dry mouth and the need to maintain 
eye lubrication with ointment. Patients are told to expect blurry vision upon awakening and 
Glycopyrrolate 0.2 mg with 30 mg lidocaine IV
Propofol 50–100 mcg/kg−1 minibolus repeated to 60 < BIS < 75 with baseline EMG
Propofol infusion rate start 25 mcg/kg−1/min−1
Adjust infusion rate as needed to maintain 60 < BIS < 75 with baseline EMG
Ketamine 50 mg IV 3 minutes prior to local analgesia injection
Lidocaine 1 mg/lb−1 or 2 mg/kg−1 IV STAT for laryngospasm
Labetalol 10 mg iv for HR > 100–110. Avoid if patient asthmatic
Table 4. Clinical pathway.
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that it is resolved when the ointment is wiped from their eyes. One patient in the author’s 
40-year career became panic-stricken upon emergence thinking something bad had hap-
pened to her eyes. Full disclosure to avoid repetition of this unfortunate patient’s experience 
is strongly recommended.
Ketamine increases salivation. Glycopyrrolate causes less tachycardia and, for that reason, is 
chosen as an antisialagogue in preference to atropine. Because propofol can sometimes cause 
patient discomfort, lidocaine is added to the glycopyrrolate. The patient is advised to tell the 
anesthesiologist if there is additional aching during induction so that more lidocaine can be 
administered. Propofol ache is more common with distally placed IV.
Between 1992 and 1997, a 50-ml IV bag with 400 mg (40 ml) propofol was connected to a 
60 drops/ml IV set (mini-drip, pedi-drip, micro-drip). The initial rate was set to the patient’s 
heart rate and adjusted until loss of lid reflex and loss of verbal response were observed. 
This was a qualitative approach that was far more subjective and less reproducible. After the 
demand for the propofol numbers for publication, the author began using an infusion pump. 
A completely programmable, albeit more expensive, infusion pump is better than less expen-
sive, commonly found pumps that only permit settings of 25, 50, 75 or 100 mcg/kg/min. The 
ability to deliver a separate bolus in addition to maintaining an infusion rate is also important. 
This quantitative approach along with BIS/EMG monitoring makes “Goldilocks” anesthesia 
numerically reproducible.
Set the pump to deliver propofol for 50 mcg/kg minibolus. Induce with miniboluses given in 
one after another until a decrease in the real-time frontalis muscle electromyogram (EMG) is 
observed (see YouTube Going under with Goldilocks anesthesia). The BIS value and trend line 
will display behind the EMG as it is based on algorithm-derived information that is delayed 
from real time by 15–30 s.
The induction goal is to observe whether or not 25 mcg/kg/min basal infusion rate is suffi-
cient to maintain 60 < BIS < 75 with baseline EMG. Bolus with 50–100 mcg/kg to maintain BIS 
<75 and upwardly adjust the basal propofol rate to 35–50 mcg/kg/min to maintain that level 
PRIOR to administering ketamine. Most patients have been maintained at 60 < BIS < 75 with 
baseline EMG with propofol 25–50 mcg/kg/min. However, as little as 2.5 mcg/kg/min and as 
much as 200 mcg/kg/min propofol have also been observed by the author in his 20-year, >4000 
patient clinical experience.
Avoid the textbook advice of 1–2 mg/kg propofol bolus for induction. A bolus will produce 
peak propofol levels in the brain quickly and just as quickly begin to redistribute, decreasing a 
protective level just as the ketamine arrives to the brain. The brain may then not be protected 
from ketamine side effects when that drug is administered. The value of the brain monitored, 
incremental induction is providing a numerically reproducible, stable propofol brain level 
to prevent negative ketamine side effects [13]. The very sensitive as well as the very resistant 
patient can be identified from the outset of the case rather than trying to understand a body 
weight–derived dose effect. Lastly, the incremental propofol induction preserves baseline blood 
pressure as well as the muscles that maintain a patent airway, i.e. the temporalis, masseter, orbi-
cularis and genioglossus. Nevertheless, one must always be prepared with available bag mask 
ventilation and suction for the exceptional patient, no matter how often it will be unnecessary.
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Only after the patient’s propofol level has stabilized should the 50 mg ketamine, independent 
of body weight, be given, 3 minutes prior to local analgesia injection. Any patient movement 
accompanied with an EMG spike during injection must be given more propofol to drive the 
EMG spike back to the baseline. As little as repeated 100 mcg/kg propofol boluses or as much 
as 200–400 mcg/kg propofol boluses may be required. An upward basal rate should be consid-
ered to maintain the patient’s propofol level at 60 < BIS < 75 with baseline EMG.
The surgeon should inject as much of the proposed surgical field(s) with the initial ketamine 
dose whenever possible. Review of 1000 patient records demonstrated 80% were performed 
with one or two 50 mg ketamine doses. Aggregate ketamine doses greater than 200 mg were 
associated with prolonged emergence. Many surgeons are concerned that the lidocaine or 
epinephrine effect will not last if a lengthy procedure is contemplated. Long experience with 
Klein’s ultradilute solution [21] has shown that concern is unwarranted even in 6-hour cases. 
Ketamine is to facilitate a painless injection of ‘virgin’ surgical fields and is not necessary for 
reinjections when needed.
6. Laryngospasm
The traditional crowing sound of incompletely closed vocal cords is rarely seen with 
“Goldilocks” anesthesia. The type of laryngospasm is characterized by complete vocal cord 
closure. The only prodrome is a cough or a sneeze. The traditional remedies of anterior jaw 
thrust and positive pressure ventilation are ineffective in dealing with ketamine-associated 
laryngospasm. The author has consistently been successful treating this type of laryngospasm 
with IV lidocaine 1 mg/lb or 2 mg/kg given STAT whenever a cough or sneeze is observed.
Spontaneous ventilation preservation is a hallmark of successful “Goldilocks” anesthesia. The 
use of succinylcholine (SCh) will produce a patient with very painful postoperative muscle 
pains. SCh is not recommended as it is an MH trigger as opposed to nontriggering propofol 
or ketamine. Nondepolarizing rocuronium in small doses is a possibility but also defeats the 
value of spontaneous ventilation even with its short duration of action. Propofol elevates the 
lidocaine seizure threshold. The author has not observed lidocaine-induced seizures when 
treating laryngospasm with IV lidocaine. However, in extremely rare cases, severe bradycar-
dia, even asystole, may be seen with multiple IV lidocaine injections. Preemptive lidocaine 
should be considered optional. Consider deepening propofol level after 2–3 lidocaine doses 
are required to break the laryngospasm.
7. Pitfalls to avoid
Anytime the words propofol and ketamine are used, readers too often think ketofol, the 
admixture of the two agents in the same syringe [22]. There are many permutations of the ideal 
ratio of propofol to ketamine. Mixing the two agents makes it very difficult, if not impossible, 
to differentiate when adequate hypnosis occurs as well as when midbrain NMDA receptor 
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saturation occurs. “Goldilocks” anesthesia provides numerically reproducible propofol levels 
to define adequate hypnosis as well as the absence of EMG spikes with local anesthesia injec-
tion to define midbrain NMDA receptor saturation (Table 5).
Propofol ketamine is like the martini cocktail wherein the propofol is the ‘vodka’ and the 
ketamine is the ‘olive.’ Ketofol is when the propofol in mixed with the ketamine. These are 
two very different approaches that should never be confused with one another. Do not mix 
propofol with ketamine.
Propofol hypnosis is protective of ketamine hallucinations [13]. Do not give ketamine 
before propofol hypnosis. Bolus propofol induction will not provide a stable CNS propofol 
level to protect against ketamine hallucinations. Do not induce with 1–2 mg/kg propofol 
boluses.
Propofol at BIS < 75 with baseline EMG is a numerically reproducible protection against ket-
amine hallucinations. Do not give ketamine if BIS > 75 or EMG is not at baseline.
Adequate local analgesia is critical to minimizing or eliminating the need for postoperative 
opioid pain rescue. Do not fail to have the surgeon reinject the immediate area of dissection 
when patient movement occurs without EMG spike and BIS < 75. More propofol or ketamine is 
an inadequate response for patient movement at BIS < 75 with baseline EMG. Adding opioids 
instead of more local analgesia is not only inadequate to correctly deal with insufficient local 
analgesia but also increases the probability of PONV.
Aggregate ketamine doses >200 mg is associated with prolonged emergence. Do not exceed 
200 mg ketamine or give ketamine in the last 20 minutes of the case or use ketamine in 
cases less than 20 minutes. Spontaneous ventilation is a prized safety feature of “Goldilocks” 
anesthesia. Do not introduce an MH trigger like SCH to treat laryngospasm. Because of the 
Do not mix propofol and ketamine. Titrate separately to define goals of adequate hypnosis and midbrain NMDA 
saturation.
Do not give ketamine before propofol.
Do not bolus propofol for induction. Incrementally induce.
Do not give ketamine at BIS > 75.
Do not fail to provide adequate local analgesia.
Do not give opioids in lieu of adequate local analgesia.
Do not give ketamine in lieu of adequate local analgesia.
Do not exceed an aggregate ketamine dose >200 mg.
Do not give ketamine in the last 20 minutes of a case or for cases <20 minutes duration.
Do not paralyze instead of using lidocaine to break laryngospasm.
Do not use succinylcholine instead of lidocaine to treat laryngospasm.
Table 5. Pitfalls to avoid.
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subsequent need to support ventilation, rocuronium is not preferred over IV lidocaine even 
though postoperative muscle pain will not result from its use.
8. Conclusion
While many anesthesiologists have observed “Goldilocks” anesthesia administered for 
classical abdominoplasty, cognitive dissonance often prevents believing what they have 
witnessed. It is not unusual for anesthesiologists to observe patients recover in a manner 
totally unlike that of GA or neuraxial block for them to believe that what they formerly 
believed was a major invasive surgery performed with a minimally invasive anesthetic 
approach.
When the surgeon is properly prepared for his role giving adequate local analgesia, the stage 
is set for outstanding, reproducible anesthesia outcomes for elective cosmetic surgery. The 
anesthesiologist needs to understand the real-time value of BIS/EMG monitoring and use 
it for the benefit of the conduct of the case. It may also be necessary to overcome outdated, 
unproductive teaching about negative ketamine side effects.
Cosmetic surgery patients endeavor to improve their level of happiness by altering their body 
image. Propofol is a happy affect drug that nicely complements the mental recovery of these 
patients.
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